Drug Profile
Research programme: metabotropic glutamate receptor modulators - Pfizer
Alternative Names: AMN-082; GRN-529Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class
- Mechanism of Action Metabotropic glutamate receptor 5 modulators; Metabotropic glutamate receptor 7 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Major depressive disorder
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Major depressive disorder in USA (PO)